Uveal Melanoma UK National Guidelines
Melanoma Focus has purchased open access to the Uveal Melanoma UK National Guidelines written by Dr Thomas Carter et al on behalf of the Uveal Guidelines Development Groups.
Uveal melanoma is a very rare form of melanoma, which is managed differently from other melanomas. Melanoma Focus developed comprehensive guidelines in 2015. This guideline was developed by a leading clinical and research specialist multidisciplinary group with patient input. The 2022 guidelines updated the following sections:
- molecular pathology and features
- prognostic markers
- loco-regional management of hepatic predominant disease
- management of metastatic disease
- adjuvant radiation therapy
- support of patients
According to NICE methodology the areas updated in the 2022 guidelines were selected where there was a significant update in evidence. Surveillance was therefore not included within this update. It was, however, recognised that the UK medical and patient community would benefit from further guidance on post treatment metastatic surveillance of uveal melanoma and therefore an additional Guidelines Development Group was set up to review this information. The guidance was therefore further updated in 2023.
The guidelines are freely available on the European Journal of Cancer website accessible here or alternatively you can download a PDF version.
Information for patients can be found here.